Funding · Company
Aktis Oncology, Inc.
Boston, MABiotech & Pharma
Aktis Oncology, Inc. of Boston, MA has disclosed $175M across 1 Form D offering filed with the SEC on Oct 2, 2024.
$175M
Total disclosed
1
Form D offering
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0002035832Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →